Ahmed joined EFG Hermes in 2018, and is currently the lead analyst covering healthcare and pharmaceutical stocks across the MENA region. He has worked on four IPOs for Fawry (Egypt) in 2019, Sulaiman Al Habib Medical Services (KSA) in 2020, Macro Group Pharmaceuticals (Egypt) in 2022, and Fakeeh Care Group (KSA), Almoosa Health (KSA) and Nice One (KSA) in 2024. Before joining EFG Hermes, he worked as a Research Analyst at CI Capital for 3 years with the Consumer and Healthcare team. Ahmed graduated from the Germany University in Cairo (GUC) with a double major in Finance and Economics and holds a Master’s Degree in Finance from Loughborough University.